遺伝子合成市場：製品、方法、遺伝子タイプ、用途、最終用途別-2025-2030年世界予測

遺伝子合成市場は、2023年に42億4,000万米ドルと評価され、2024年には46億8,000万米ドルに達すると予測され、CAGR 10.82％で成長し、2030年には87億米ドルになると予測されています。

遺伝子合成とは、遺伝子配列をゼロから酵素的または化学的に組み立てることを指します。合成生物学において極めて重要な役割を果たし、研究者は様々な目的のために特定のDNA配列を作り出すことができます。その必要性は、所望の生物学的特性を持つ合成遺伝子を得るプロセスを、従来のクローニング法よりも大幅に短縮できることにあります。遺伝子合成の用途は、製薬、農業、ワクチン開発、産業バイオテクノロジーなど複数の領域にまたがり、最終用途の産業は製品開発、研究、治療効果に活用しています。

市場の洞察によると、遺伝子合成は、個別化医療に対する需要の増加、遺伝子工学の進歩、研究開発活動の活発化によって力強い成長軌道を描いています。遺伝子合成のコスト低下とともに、合成生物学アプリケーションの増加がこの成長をさらに後押ししています。しかし、倫理的論争、規制の複雑さ、合成遺伝子の悪用の可能性などの課題も残っています。主な限界は、長い遺伝子や高度に複雑な遺伝子を組み立てる際の技術的な複雑さであり、これはコストやリードタイムに影響する可能性があります。

特に、新しい治療薬やワクチンの開発、干ばつに強い作物の作製、バイオ燃料生産の強化など、市場開拓の機会は膨大です。企業は、合成精度を向上させ、エラー率を減少させる技術に投資することで、これらを活用することができます。さらに、研究機関との提携により、CRISPR遺伝子編集システムのようなアプリケーションの技術革新を促進することができます。

技術革新の主な分野としては、配列設計のためのより洗練されたアルゴリズムの開発、塩基対合成精度の向上、より大きな遺伝子配列を扱うための合成プロセスの拡張性の強化などが挙げられます。カスタマイズ可能なアンメットニーズに対応し、従来のバイオテクノロジー市場以外へのサービス提供を拡大することで、事業の成長はさらに加速できます。従って、競合優位性を持続させるために、企業はプロセス効率の改善と応用可能性の拡大に注力すべきであり、同時に、遺伝子合成に関連する社会的・倫理的懸念に対処するために規制状況を乗り切る必要があります。

市場力学：急速に進化する遺伝子合成市場の主要市場インサイトを公開

遺伝子合成市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界人口の慢性疾患の有病率
  • ゲノム研究活動の活発化と個別化医薬品への注目の高まり
  • 民間および公的セクターによる医薬品研究への投資の増加
• 市場抑制要因
  • 遺伝子合成を管理する厳格な規制と、プロセスに関連する高コスト
• 市場機会
  • 遺伝子合成における新技術の台頭
  • エネルギーおよび農業産業における遺伝子合成の利用
• 市場の課題
  • 合成遺伝子のサイズと複雑性の限界

ポーターの5つの力：遺伝子合成市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、遺伝子合成市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：遺伝子合成市場における外部からの影響の把握

外部マクロ環境要因は、遺伝子合成市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析遺伝子合成市場における競合情勢の把握

遺伝子合成市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス遺伝子合成市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、遺伝子合成市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界人口における慢性疾患の有病率
    • ゲノム調査活動の増加と個別化医療への注目の高まり
    • 医薬品調査への民間および公共部門による投資の増加
  • 抑制要因
    • 遺伝子合成を規制する厳しい規制とプロセスに関連する高コスト
  • 機会
    • 遺伝子合成における新たなテクノロジー
    • エネルギー・農業産業における遺伝子合成の活用
  • 課題
    • 合成遺伝子のサイズと複雑さの限界
• 市場セグメンテーション分析
  • 製品：合成遺伝子を正確に設計するソフトウェアの利用拡大
  • 方法：大規模プロジェクトにおけるチップベース合成の利用増加
  • 遺伝子タイプ：時間的制約のあるプロジェクト向けに短い遺伝子に素早くアクセスできる高速遺伝子合成の可能性が高まっています
  • 最終用途：バイオテクノロジー企業や製薬企業における革新的な医薬品の発見と治療薬の開発への注目が高まる
  • 遺伝子タイプ：特定の宿主生物における高レベルの発現に最適化された発現遺伝子の成長可能性
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 遺伝子合成市場：製品別

• ハードウェア
• サービス
  • 抗体DNA合成
  • ウイルスDNA合成
• ソフトウェア

第7章 遺伝子合成市場：方法別

• チップベースの合成
• PCRベースの酵素合成
• 固相合成

第8章 遺伝子合成市場遺伝子タイプ別

• 複雑な遺伝子
• エクスプレス遺伝子
• 標準遺伝子

第9章 遺伝子合成市場：用途別

• 病気の診断
• 遺伝子・細胞治療の開発
• ワクチン開発

第10章 遺伝子合成市場：最終用途別

• 学術機関および政府調査機関
• バイオテクノロジーおよび製薬会社
• 契約調査機関

第11章 南北アメリカの遺伝子合成市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の遺伝子合成市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの遺伝子合成市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • EvonetixとAnalog Devices Incが革新的な遺伝子合成プラットフォームを開発
  • Gyros Protein TechnologiesとBiotageが提携し、新しい自動化ソリューションでペプチド精製の効率を向上
  • シンプロジェンとギンゴバイオワークス、日本における世界のDNA製造および遺伝子治療プラットフォームサービスの加速計画を発表
  • Twist BioscienceがExpress Genes Rapid遺伝子合成サービスを開始
  • バイオテクノロジー企業が560万ポンドのシード資金を調達
  • ブルカー、フェノメックスを1億800万米ドルで買収
  • DNA合成技術の拡大を支援するためのシリーズ資金
  • NunaBio、インフラの拡張と研究開発の加速のためシード資金として190万ポンドを調達
  • エレジェン、バイオエコノミーを推進する高速長鎖DNA合成装置ENFINIA DNAを発売
  • アンサ・バイオテクノロジーズ、1005塩基のオリゴヌクレオチドの新規合成に成功と発表
  • GenScript、シンガポールでの拠点を拡大し、プレミアムな遺伝子合成サービスを提供
  • Evonetix、2,400万米ドルの資金調達を完了
  • 遺伝子合成（エンドツーエンド）インドでBarcode Biosciencesが販売開始
  • ユーロフィンズジェノミクスブルーヘロンがIVT mRNA合成サービスを開始：遺伝子発現の未来

企業一覧

• Biomatik Corporation
• Biotech Desk Pvt. Ltd.
• Twist Bioscience Corporation
• ProteoGenix SAS
• Creative Biogene
• Biotage AB
• General Biosystems, Inc.
• Ansa Biotechnologies, Inc.
• ProMab Biotechnologies, Inc.
• Barcode Biosciences Private Limited
• DNA TwoPointO Inc.
• Elabscience Biotechnology Inc.
• Eurofins Scientific SE
• Telesis Bio Inc.
• Macrogen, Inc.
• Elegen Corp.
• Gene Universal, Inc.
• Charles River Laboratories International, Inc.
• Thermo Fisher Scientific Inc.
• Synbio Technologies LLC
• Danaher Corporation
• Constructive Bio Ltd
• GenCefe Biotech Limited
• NZYTech, Lda.
• Evonetix Ltd.
• OriGene Technologies, Inc.
• BGI Genomics by BGI Group
• Boster Biological Technology
• Bioneer Corporation
• Brooks Automation Inc.
• QIAGEN N.V.
• Agilent Technologies, Inc.
• Merck KGaA
• AstraZeneca PLC
• Ginkgo Bioworks Holdings, Inc.
• GenScript Biotech Corporation
• Camena Bioscience
• Azenta, Inc.
• BioCat GmbH by AddLife AB
• Applied Biological Materials Inc.

LIST OF FIGURES

• FIGURE 1. GENE SYNTHESIS MARKET RESEARCH PROCESS
• FIGURE 2. GENE SYNTHESIS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. GENE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. GENE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GENE SYNTHESIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GENE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GENE SYNTHESIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GENE SYNTHESIS MARKET DYNAMICS
• TABLE 7. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GENE SYNTHESIS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ANTIBODY DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VIRAL DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CHIP-BASED SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GENE SYNTHESIS MARKET SIZE, BY PCR-BASED ENZYME SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GENE SYNTHESIS MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GENE SYNTHESIS MARKET SIZE, BY COMPLEX GENE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL GENE SYNTHESIS MARKET SIZE, BY EXPRESS GENE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL GENE SYNTHESIS MARKET SIZE, BY STANDARD GENE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL GENE SYNTHESIS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL GENE SYNTHESIS MARKET SIZE, BY GENE & CELL THERAPY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL GENE SYNTHESIS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL GENE SYNTHESIS MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL GENE SYNTHESIS MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL GENE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 49. CANADA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. CANADA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 51. CANADA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 52. CANADA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 53. CANADA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. CANADA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES GENE SYNTHESIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 81. CHINA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. CHINA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 83. CHINA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 84. CHINA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 85. CHINA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. CHINA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 87. INDIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. INDIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 89. INDIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 90. INDIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 91. INDIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. INDIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 190. ITALY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 191. ITALY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 192. ITALY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 193. ITALY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 194. ITALY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. ITALY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 214. POLAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 215. POLAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 216. POLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 217. POLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 218. POLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. POLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 220. QATAR GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 221. QATAR GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 222. QATAR GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 223. QATAR GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 224. QATAR GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. QATAR GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY GENE TYPE, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM GENE SYNTHESIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 280. GENE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 281. GENE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2023

The Gene Synthesis Market was valued at USD 4.24 billion in 2023, expected to reach USD 4.68 billion in 2024, and is projected to grow at a CAGR of 10.82%, to USD 8.70 billion by 2030.

Gene synthesis refers to the enzymatic or chemical assembly of gene sequences from scratch. It plays a pivotal role in synthetic biology, enabling researchers to create specific DNA sequences for various purposes. Its necessity arises from its ability to expedite the process of obtaining synthetic genes with desired biological properties, which is significantly faster than traditional cloning methods. Applications of gene synthesis span multiple domains, including pharmaceuticals, agriculture, vaccine development, and industrial biotechnology, with end-use industries leveraging it for product development, research, and therapeutic efficacy.

Market insights indicate a robust growth trajectory for gene synthesis driven by increasing demand for personalized medicine, advancements in genetic engineering, and heightened R&D activities. The rise in synthetic biology applications, alongside decreasing costs of gene synthesis, further fuels this growth. However, challenges persist, such as ethical controversies, regulatory complexities, and potential misuse of synthetic genes. A major limitation is the technical complexity involved in assembling long or highly complex genes, which can affect costs and lead time.

Opportunities in the market are vast, particularly in the development of new therapeutic drugs and vaccines, crafting drought-resistant crops, and enhancing biofuel production. Companies can capitalize on these by investing in technologies that improve synthesis accuracy and reduce error rates. Additionally, partnerships with research institutions could expedite innovations in applications like CRISPR gene-editing systems.

Key areas for innovation include developing more sophisticated algorithms for sequence design, improving base-pair synthesis accuracy, and enhancing the scalability of synthesis processes to handle larger genetic sequences. Business growth can be further accelerated by addressing the unmet needs in customizable gene synthesis and expanding service offerings to non-traditional biotech markets. Hence, for sustained competitive advantage, companies should focus on improving process efficiencies and expanding application potential, all while navigating the regulatory landscape to address societal and ethical concerns associated with gene synthesis.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Synthesis Market

The Gene Synthesis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of chronic conditions among the global population
  • Increasing genomics research activities and rising focus on personalized medicines
  • Growing investments by the private and public sectors in pharmaceutical research
• Market Restraints
  • Strict regulations governing gene synthesis and high cost associated with the process
• Market Opportunities
  • Emerging new technologies in gene synthesis
  • Utilization of gene synthesis in energy and agriculture industries
• Market Challenges
  • Limitations in size and complexity of synthetic genes

Porter's Five Forces: A Strategic Tool for Navigating the Gene Synthesis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Synthesis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Synthesis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Synthesis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Synthesis Market

A detailed market share analysis in the Gene Synthesis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Synthesis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Synthesis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Gene Synthesis Market, highlighting leading vendors and their innovative profiles. These include Biomatik Corporation, Biotech Desk Pvt. Ltd., Twist Bioscience Corporation, ProteoGenix SAS, Creative Biogene, Biotage AB, General Biosystems, Inc., Ansa Biotechnologies, Inc., ProMab Biotechnologies, Inc., Barcode Biosciences Private Limited, DNA TwoPointO Inc., Elabscience Biotechnology Inc., Eurofins Scientific SE, Telesis Bio Inc., Macrogen, Inc., Elegen Corp., Gene Universal, Inc., Charles River Laboratories International, Inc., Thermo Fisher Scientific Inc., Synbio Technologies LLC, Danaher Corporation, Constructive Bio Ltd, GenCefe Biotech Limited, NZYTech, Lda., Evonetix Ltd., OriGene Technologies, Inc., BGI Genomics by BGI Group, Boster Biological Technology, Bioneer Corporation, Brooks Automation Inc., QIAGEN N.V., Agilent Technologies, Inc., Merck KGaA, AstraZeneca PLC, Ginkgo Bioworks Holdings, Inc., GenScript Biotech Corporation, Camena Bioscience, Azenta, Inc., BioCat GmbH by AddLife AB, and Applied Biological Materials Inc..

Market Segmentation & Coverage

This research report categorizes the Gene Synthesis Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Hardware, Services, and Software. The Services is further studied across Antibody DNA Synthesis and Viral DNA Synthesis.
• Based on Method, market is studied across Chip-Based Synthesis, PCR-Based Enzyme Synthesis, and Solid-Phase Synthesis.
• Based on Gene Type, market is studied across Complex Gene, Express Gene, and Standard Gene.
• Based on Application, market is studied across Disease Diagnosis, Gene & Cell Therapy Development, and Vaccine Development.
• Based on End-use, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of chronic conditions among the global population
    • 5.1.1.2. Increasing genomics research activities and rising focus on personalized medicines
    • 5.1.1.3. Growing investments by the private and public sectors in pharmaceutical research
  • 5.1.2. Restraints
    • 5.1.2.1. Strict regulations governing gene synthesis and high cost associated with the process
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging new technologies in gene synthesis
    • 5.1.3.2. Utilization of gene synthesis in energy and agriculture industries
  • 5.1.4. Challenges
    • 5.1.4.1. Limitations in size and complexity of synthetic genes
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Expanding usage of software that helps design synthetic genes accurately
  • 5.2.2. Method: Rising utilization of chip-based synthesis for large-scale projects
  • 5.2.3. Gene Type: Growing potential for express gene synthesis that provides quick access to shorter genes for time-sensitive projects
  • 5.2.4. End-use: Increasing focus on innovative drug discovery and therapeutic development across biotechnology and pharmaceutical companies
  • 5.2.5. Gene Type: Growing potential of express genes that are optimized for high levels of expression in specific host organisms
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Gene Synthesis Market, by Product

• 6.1. Introduction
• 6.2. Hardware
• 6.3. Services
  • 6.3.1. Antibody DNA Synthesis
  • 6.3.2. Viral DNA Synthesis
• 6.4. Software

7. Gene Synthesis Market, by Method

• 7.1. Introduction
• 7.2. Chip-Based Synthesis
• 7.3. PCR-Based Enzyme Synthesis
• 7.4. Solid-Phase Synthesis

8. Gene Synthesis Market, by Gene Type

• 8.1. Introduction
• 8.2. Complex Gene
• 8.3. Express Gene
• 8.4. Standard Gene

9. Gene Synthesis Market, by Application

• 9.1. Introduction
• 9.2. Disease Diagnosis
• 9.3. Gene & Cell Therapy Development
• 9.4. Vaccine Development

10. Gene Synthesis Market, by End-use

• 10.1. Introduction
• 10.2. Academic & Government Research Institutes
• 10.3. Biotechnology & Pharmaceutical Companies
• 10.4. Contract Research Organizations

11. Americas Gene Synthesis Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Gene Synthesis Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Gene Synthesis Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Evonetix and Analog Devices Inc To Progress Revolutionary Gene Synthesis Platform
  • 14.3.2. Gyros Protein Technologies and Biotage Partner to Advance Peptide Purification Efficiency With New Automated Solution
  • 14.3.3. Synplogen and Ginkgo Bioworks Announce Plans to Accelerate Global DNA Manufacturing and Gene Therapy Platform Services in Japan
  • 14.3.4. Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
  • 14.3.5. Biotech Firm Closes GBP 5.6 million Seed Financing
  • 14.3.6. Bruker to Buy PhenomeX For USD 108 Million
  • 14.3.7. Series Funding to Support Expansion of DNA Synthesis Technology
  • 14.3.8. NunaBio Raises GBP 1.9M In Seed Funding To Expand Infrastructure And Accelerate R&D
  • 14.3.9. Elegen Launches ENFINIA DNA, Rapid Long DNA Synthesis to Power the Bioeconomy
  • 14.3.10. Ansa Biotechnologies Announces Successful de novo Synthesis of Oligonucleotide at 1005 Bases
  • 14.3.11. GenScript Expands Footprint in Singapore to Provide Premium Gene Synthesis Service
  • 14.3.12. Evonetix Closes USD 24 million Financing
  • 14.3.13. Gene Synthesis (End-to-End) Now In India At Barcode Biosciences
  • 14.3.14. Eurofins Genomics Blue Heron launches IVT mRNA Synthesis Service: The Future of Gene Expression

Companies Mentioned

• 1. Biomatik Corporation
• 2. Biotech Desk Pvt. Ltd.
• 3. Twist Bioscience Corporation
• 4. ProteoGenix SAS
• 5. Creative Biogene
• 6. Biotage AB
• 7. General Biosystems, Inc.
• 8. Ansa Biotechnologies, Inc.
• 9. ProMab Biotechnologies, Inc.
• 10. Barcode Biosciences Private Limited
• 11. DNA TwoPointO Inc.
• 12. Elabscience Biotechnology Inc.
• 13. Eurofins Scientific SE
• 14. Telesis Bio Inc.
• 15. Macrogen, Inc.
• 16. Elegen Corp.
• 17. Gene Universal, Inc.
• 18. Charles River Laboratories International, Inc.
• 19. Thermo Fisher Scientific Inc.
• 20. Synbio Technologies LLC
• 21. Danaher Corporation
• 22. Constructive Bio Ltd
• 23. GenCefe Biotech Limited
• 24. NZYTech, Lda.
• 25. Evonetix Ltd.
• 26. OriGene Technologies, Inc.
• 27. BGI Genomics by BGI Group
• 28. Boster Biological Technology
• 29. Bioneer Corporation
• 30. Brooks Automation Inc.
• 31. QIAGEN N.V.
• 32. Agilent Technologies, Inc.
• 33. Merck KGaA
• 34. AstraZeneca PLC
• 35. Ginkgo Bioworks Holdings, Inc.
• 36. GenScript Biotech Corporation
• 37. Camena Bioscience
• 38. Azenta, Inc.
• 39. BioCat GmbH by AddLife AB
• 40. Applied Biological Materials Inc.